Narrow versus broad spectrum antibacterials: Factors in the selection of pneumococcal resistance to β-lactams

Drugs

Volumn 62, Issue 9, 2002, Pages 1289-1294

  Carbon, Claude ^a   Isturiz, Raul ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Centro Medico Docente La Trinidad   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPENICILLIN; AMOXICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; COTRIMOXAZOLE; DALFOPRISTIN; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE; QUINUPRISTIN; TETRACYCLINE DERIVATIVE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL TRANSMISSION; CHILD; COMMUNITY MEDICINE; DAY CARE; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; DOSE CALCULATION; DRUG CHOICE; DRUG INDICATION; DRUG USE; FEVER; HUMAN; LABORATORY TEST; LOWER RESPIRATORY TRACT INFECTION; MEDICAL PRACTICE; MENINGITIS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR BIOLOGY; MULTIDRUG RESISTANCE; NONHUMAN; OTITIS MEDIA; PENICILLIN RESISTANCE; PHARYNGITIS; REVIEW; RUGBY; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TREATMENT INDICATION; UPPER RESPIRATORY TRACT INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; DRUG UTILIZATION; HUMANS; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0036073473     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200262090-00001     Document Type: Review

References (46)

1. Pneumococcus and the Brooklyn connection
2. New faces of an old pathogen: Emergence and spread of multidrug-resistant streptococcus pneumoniae
3. A compilation of studies assessing the in vitro activity of meropenem and comparators in 84 laboratories throughout Europe
4. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada
5. Fluoroquinolone resistance in Streptococcus pneumoniae
6. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance
7. In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin and pristinamycin in Streptococcus pneumoniae
8. In vitro selection of resistance to four β-lactams and azithromycin in Streptococcus pneumoniae
9. Low dosage and long treatment duration of β-lactam. Risk factors for carriage of penicillin-resistant Streptococcus pneumoniae
10. The antibiotic selective process: Concentration-specific amplification of low-level resistant populations
11. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study
12. Multiply resistant pneumococcus causing meningitis: Its epidemiology within a day care center
13. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci
14. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio
15. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: Risk factors, susceptibility patterns and antimicrobial management
16. High prevalence of multi-drug-resistant Streptococcus pneumoniae among children in a rural Kentucky community
17. Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin
18. Prophylaxis with amoxicillin or sulfisoxazole for otitis media: Effect on the recovery of penicillin-resistant bacteria from children
19. Carriage of penicillin-resistant pneumococci in a military population in Washington DC: Risk factors and correlation with clinical isolates
20. Risk factors for isolation of Streptococcus pneumoniae with decreased susceptibility to penicillin G from patients infected with human immunodeficiency virus
21. Previous antibiotic consumption and other risk factors for carriage of penicillin-resistant Streptococcus pneumoniae in children
22. Acquisition, carriage and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in southern Israel
23. Carriage of multidrug-resistant Streptococcus pneumoniae and impact of chemoprophylaxis during an outbreak of meningitis at a day care center
24. Members of the Toronto Child Care Study Group. Streptococcus pneumoniae carriage in children attending 59 child care centers
25. Antimicrobial resistance in hospital organisms and its relation to antibiotic use
26. Duration of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae: Experiences from the South Swedish Pneumococcal Intervention Project
27. The relationship between the volume of antimicrobial consumption in human community and the frequency of resistance
28. Antibiotic use in developing countries
29. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe
30. Evolving resistance patterns of Streptococcus pneumoniae: A link with long acting macrolide consumption?
31. Molecular evolution in a multidrug-resistant lineage of Streptococcus pneumoniae: Emergence of strains belonging to serotype 6B Icelandic clone that lost antibiotic resistance traits
32. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in Group A streptococci
33. Continued decline in the incidence of penicillin non-susceptible pneumococci in Iceland
34. A biological price of antibiotic resistance: Major changes in the peptidoglycan structure of penicillin resistant pneumococci
35. Relationships between capsular type, penicillin susceptibility, and mouse virulence of human Streptococcus pneumoniae isolates in mice
36. The cost of resistance: Can penicillin resistant strains of Streptococcus pneumoniae cause lethal murine pneumonia?
37. Virulence of antibiotic resistant Salmonella typhimurium
38. Pneumonia caused by penicillin-nonsusceptible and penicillin-susceptible pneumococci in adults: A case control study
39. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997
40. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia
41. In vitro selective antibiotic concentrations of beta-lactams for penicillin-resistant Streptococcus pneumoniae
42. Change in nasopharyngeal carriage of Streptococcus pneumoniae resulting from antibiotic therapy for acute otitis media in children
43. Increasing prevalence of penicillin-resistant pneumococcal infections in children in southern Israel: Implications for future immunization policies
44. Which pneumococcal serogroup cause most invasive disease: Implications for conjugate vaccine formulation and use
45. The contribution of specific pneumococcal serogroups to different disease manifestations: Implications for conjugate vaccine formulation and use